Oncodesign Services, a leading European CRO in preclinical drug discovery acquires ZoBio, a CRO specialized in small molecule drug discovery
Oncodesign Services (ODS), a leading Contract Research Organization specialized in drug discovery and preclinical services, announces its international expansion through the acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery.